Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

23.31
-0.1800-0.77%
Post-market: 23.29-0.0200-0.09%18:35 EDT
Volume:2.52M
Turnover:59.31M
Market Cap:3.70B
PE:-8.10
High:24.65
Open:24.17
Low:23.21
Close:23.49
52wk High:24.65
52wk Low:12.58
Shares:158.59M
Float Shares:144.00M
Volume Ratio:1.30
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8782
EPS(LYR):-2.9700
ROE:-49.59%
ROA:-26.95%
PB:3.99
PE(LYR):-7.85

Loading ...

Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Major Issues Report

Form 8-K - Current report